GlassScriptPhysician profile
Adewunmi O Adeyemo
NPI 1427289883
$18,094.15
in general payments reported to CMS, 2019-2025
25 companies · $922 in 2025
The $922 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $385 · 2021: $906 · 2022: $2,332 · 2023: $806 · 2024: $1,236 · 2025: $922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,963.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,783.69 | 2019-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $2,313.70 | 2021-2024 | Interstim, Clydesdale Ptc Spinal System, Signia |
| Medical Device Business Services, INC. | $1,571.36 | 2019 | |
| Ethicon US, LLC | $1,080.75 | 2019-2025 | Enseal, Echelon Circular, Echelon; Endopath |
| Integra Lifesciences Corporation | $604.95 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Tela Bio, INC. | $552.05 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Takeda Pharmaceuticals U.S.A., INC. | $382.15 | 2019-2024 | Entyvio |
| E.R. Squibb & Sons, L.L.C. | $335.15 | 2021-2022 | |
| Axonics, INC. | $204.79 | 2020-2023 | Axonics |
| Medtronic USA, INC. | $196.91 | 2019-2020 | |
| Aroa Biosurgery Incorporated | $160.17 | 2024 | |
| Rti Surgical, INC | $127.62 | 2022 | |
| Globus Medical, INC. | $116.03 | 2025 | Reline |
| Smith+Nephew, INC. | $101.96 | 2020-2021 | |
| Covidien LP | $100.64 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $89.28 | 2021-2023 | Zeposia |
| Biotissue Holdings INC. | $86.55 | 2025 | |
| Conmed Corporation | $51.48 | 2024 | Airseal |
| Baudax Bio INC. | $51.07 | 2022 | |
| Stryker Corporation | $45.55 | 2024-2025 | Triathlon |
| Janssen Biotech, INC. | $36.86 | 2021-2025 | Simponi Aria, Tremfya, Stelara |
| Davol INC. | $35.70 | 2019 | |
| Abbvie INC. | $27.37 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $19.91 | 2022 | |
| Innocoll Pharmaceuticals Limited | $18.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adewunmi Adeyemo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.